Skip to search boxSkip to navigationSkip to main content

Human Mesenchymal Stem Cells Partially Reverse Infertility in Chemotherapy-Induced Ovarian Failure

  • Sara A. Mohamed
    ,
  • Shahinaz M. Shalaby
    ,
  • Mohamed Abdelaziz
    ,
  • ,
  • William D Hill
    ,
  • Nahed Ismail
*Corresponding author for this work
Scholary Output:
Contribution to journal
Article
Research
Peer-review

Open access

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

Introduction: Chemotherapy is the most commonly used modality to treat human cancers; however, in many cases it causes irreversible ovarian failure. In this work, we plan to evaluate the restorative function of human bone marrow mesenchymal stem cells (BMSCs) in a chemotherapy-induced ovarian failure mouse model. Methods: Acclimatized 4 to 6 week-old female mice (C57BL/6) were assigned randomly to a vehicle-treated control group (group 1), chemotherapy-treated group followed by vehicle alone (group 2), or chemotherapy-treated group followed by stem cell intraovarian injection (group 3). Outcomes were evaluated using immunohistochemistry (IHC), serum hormonal assays, and estrous cycle monitoring and breeding potential. Results: Post BMSCs administration, group 3 promptly showed detectable vaginal smears with estrogenic changes. Increase in total body weight, ovarian weight, and weight of estrogen-responsive organs (uterus and liver) was observed at 2 weeks and continued to end of the experiment. Hematoxylin and Eosin histological evaluation of the ovaries demonstrated a higher mean follicle count in group 3 than in group 2. Group 3 had lower follicle-stimulating hormone (FSH) levels (P =.03) and higher anti-Müllerian hormone serum (AMH) levels (P =.0005) than group 2. The IHC analysis demonstrated higher expression of AMH, FSH receptor, inhibin A, and inhibin B in growing follicles of group 3 versus group 2. Tracking studies demonstrated that human BMSCs evenly repopulated the growing follicles in treated ovaries. Importantly, breeding data showed significant increases in the pregnancies numbers, 2 pregnancies in group 1 and 12 in group 3 (P =.02). Conclusions: Intraovarian administered BMSCs are able to restore ovarian hormone production and reactivate folliculogenesis in chemotherapy-induced ovarian failure mouse model.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Research
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 51-63 (13 pages)

Journal (Volume, Issue Number)

Reproductive Sciences (Volume 25, Issue 1)

Publication milestones

  • Published - 01/01/2018

Publication status

Published - 01/01/2018

ISSN

1933-7191

Publication IDs

  • Scopus: 85037972146
  • PubMed: 28460567

Publication metrics

Metrics

Scopus
citations
SciVal
citations
39
SciVal
FWCI
6.57
SciVal
Author count
7
SciVal
Paper percentile
97
SciVal
Top percentile
5
Fractional count
3
Fractional count
0.43
Fractional count
4
Fractional count
0.57
Fractional count
3
Fractional count
1

PlumX, opens in new tab

Captures
96
Citation count
121

Funding Details

The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported in part by Augusta University Startup package, (Ayman Al-Hendy) and the core lab, which is supported by the Eunice Kennedy Shriver NICHD/NIH (SCCPIR) Grant U54-HD28934. We also appreciate the core lab which is supported by the Eunice Kennedy Shriver NICHD/NIH (SCCPIR) Grant U54-HD28934.
FundersFunding number
NICHD
U54HD028934
NICHD
-Augusta University-